Related Experiment Videos
Detection of antibodies to streptococcal mucopeptide in patients with rheumatic disorders and normal controls
Abstract:
Bacterial mucopeptide is an integral part of bacterial cell walls and is therefore ubiquitous in our environment. An enhanced degree of humoral immunity has ben detected not only in patients with acute rheumatic fever (ARF), with a known recent response to streptococci, but also in patients with adult and juvenile rheumatoid arthritis (RA and JRA). Our studies confirmed this association with ARF and JRA using a precipitin system as well as a radioimmunoassay to detect IgG anti-mucopeptide antibodies. In those with adult RA, either IgM or IgA rheumatoid factors or IgM or IgA antibodies specific for mucopeptide were responsible for the increased incidence of precipitins to mucopeptide in the RA patients detected in this and other studies. No differences in the specificities of the anti-mucopeptide antibodies were noted between the various patient populations as there were no lines of partial identity or nonidentity when examined by Ouchterlony double diffusion analyses. Additionally, no differences of anti-mucopeptide antibody were observed when the sera from these same patient populations were examined employing inhibition studies utilizing N-acetylglucosamine and rhamnose.
Insights
Bacterial mucopeptide antibodies are linked to rheumatic diseases. Studies show increased IgG anti-mucopeptide antibodies in acute rheumatic fever (ARF) and rheumatoid arthritis (RA) patients, indicating a potential immune response.
Area of Science:
- Immunology
- Microbiology
- Rheumatology
Background:
- Bacterial mucopeptide, a component of bacterial cell walls, is widespread in the environment.
- Elevated humoral immunity has been observed in patients with acute rheumatic fever (ARF) and rheumatoid arthritis (RA), including juvenile RA (JRA).
- Previous research suggests an association between streptococcal infections and ARF.
Purpose of the Study:
- To investigate the association between bacterial mucopeptide and immune responses in patients with ARF, adult RA, and JRA.
- To characterize the specificities of anti-mucopeptide antibodies in these patient populations.
Main Methods:
- Utilized a precipitin system and radioimmunoassay to detect IgG anti-mucopeptide antibodies.
- Employed Ouchterlony double diffusion analyses to compare antibody specificities.
- Conducted inhibition studies using N-acetylglucosamine and rhamnose to further analyze antibody differences.
Main Results:
- Confirmed an association between anti-mucopeptide antibodies and ARF and JRA.
- In adult RA patients, IgM or IgA rheumatoid factors or specific mucopeptide antibodies contributed to increased precipitins.
- No significant differences in anti-mucopeptide antibody specificities were found across ARF, RA, and JRA patient groups via diffusion or inhibition assays.
Conclusions:
- The study confirms a link between bacterial mucopeptide antibodies and rheumatic diseases like ARF and RA.
- The findings suggest a common immunological basis or cross-reactivity involving bacterial mucopeptide in these conditions.
- Further research is warranted to elucidate the precise role of bacterial mucopeptide in the pathogenesis of rheumatic diseases.